Fullpower®-AI Sleep Research & Technology Expertise
Sleeptracker-AI® research is now validated by Stanford University, Division of Sleep Medicine.
Sleep is one third of our lives; wearables are invasive. Yet, sleep is a crucial signpost for health and changes in health. All of an individual's live sleep experience is outside of a sleep lab. However, clinicians and researchers fly blind to this aspect of an individual's sleep and changes over time. Sleeptracker-AI's network of sleepers is highly motivated to participate in managing their health. We complement their active engagement with the passive deep analysis of their anonymized data with their consent.
A significant fraction of individuals over the age of 30 show breathing anomalies during sleep, with estimates ranging up to 50%, including some of the more severe varieties. This ranges from habitual snoring to life-threatening COPD and sleep apnea (including Central and Obstructive). These conditions often correlate with diabetes, hypertension, stroke, and heart attack risks. The Sleeptracker-AI platform delivers the first in-home, non-invasive, automatic, long-term sleep analysis solution, together with all the necessary data science tools and analytical dashboards powered by AI. 
- Patient Generated Health Data, HealthIT.gov https://www.healthit.gov/topic/scientific-initiatives/pcor/patient-generated-health-data-pghd
- Garvey JF, Pengo MF, Drakatos P, Kent BD. Epidemiological aspects of obstructive sleep apnea. J Thorac Dis. 2015;7(5): 920-929.
- Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310-318.
- Adeloye D, Chua S, et al. Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015 Dec;5(2):020415.
Fullpower®-AI synthetic control arms use validated, real-world person/patient generated sleep data as comparators for clinical trials instead of collecting data from patients recruited for a trial who have been assigned to the control arm. This halves the number of participants needed for clinical trials, speeding up trials and decreasing their cost.
- Synthetic Control Arms can save time and money in clinical trials, StatNews.com https://www.statnews.com/2019/02/05/synthetic-control-arms-clinical-trials/